Yanni Ding
YOU?
Author Swipe
View article: Dynamic Nomogram Predicts Overall Survival in Patients With Occult Breast Cancer: a Population-based Analysis
Dynamic Nomogram Predicts Overall Survival in Patients With Occult Breast Cancer: a Population-based Analysis Open
Background: Due the rarity of occult breast cancer (OBC), no precise prognostic instruments were available to assess the overall survival (OS) in patients with OBC. The aim of this study is to construct a nomogram for predicting the OS pro…
View article: Additional file 3 of Characterization of alternative splicing events and prognostic signatures in breast cancer
Additional file 3 of Characterization of alternative splicing events and prognostic signatures in breast cancer Open
Additional file 3: Table S3. List of 404 splice factorsR3.
View article: Additional file 6 of Characterization of alternative splicing events and prognostic signatures in breast cancer
Additional file 6 of Characterization of alternative splicing events and prognostic signatures in breast cancer Open
Additional file 6: Table S6. Differential expressed genesR3.
View article: Additional file 8 of Characterization of alternative splicing events and prognostic signatures in breast cancer
Additional file 8 of Characterization of alternative splicing events and prognostic signatures in breast cancer Open
Additional file 8: Table S8. Correlation between AS events and SFsR3.
View article: Additional file 5 of Characterization of alternative splicing events and prognostic signatures in breast cancer
Additional file 5 of Characterization of alternative splicing events and prognostic signatures in breast cancer Open
Additional file 5: Table S5. Detailed results of GO and KEGG analysesR3.
View article: Additional file 4 of Characterization of alternative splicing events and prognostic signatures in breast cancer
Additional file 4 of Characterization of alternative splicing events and prognostic signatures in breast cancer Open
Additional file 4: Table S4. ER, PR, and HER2 correlationR3.
View article: Additional file 1 of Characterization of alternative splicing events and prognostic signatures in breast cancer
Additional file 1 of Characterization of alternative splicing events and prognostic signatures in breast cancer Open
Additional file 1: Table S1. Differential AS eventsR3.
View article: Additional file 2 of Characterization of alternative splicing events and prognostic signatures in breast cancer
Additional file 2 of Characterization of alternative splicing events and prognostic signatures in breast cancer Open
Additional file 2: Table S2. AS events significantly associated with OSR3.
View article: Additional file 9 of Characterization of alternative splicing events and prognostic signatures in breast cancer
Additional file 9 of Characterization of alternative splicing events and prognostic signatures in breast cancer Open
Additional file 9: Table S9. Prognostic SFsR3.
View article: Additional file 7 of Characterization of alternative splicing events and prognostic signatures in breast cancer
Additional file 7 of Characterization of alternative splicing events and prognostic signatures in breast cancer Open
Additional file 7: Table S7. AS events Ratio for 7 typesR3.
View article: Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer
Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer Open
The survival-associated AS events and prognostic signatures identified in this study can serve as useful tool for predicting prognosis of patients with PC. Moreover, the SF-AS regulatory networks may provide clues for the mechanisms underl…
View article: Prognostic role of alternative splicing events in head and neck squamous cell carcinoma
Prognostic role of alternative splicing events in head and neck squamous cell carcinoma Open
Background Aberrant alternative splicing (AS) is implicated in biological processes of cancer. This study aims to reveal prognostic AS events and signatures that may serve as prognostic predictors for head and neck squamous cell carcinoma …